Sonoma Pharmaceuticals Inc banner

Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 2.61 USD -6.79% Market Closed
Market Cap: $4.4m

Profitability Summary

Sonoma Pharmaceuticals Inc's profitability score is 25/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

25/100
Profitability
Score
25/100
Profitability
Score

Margins

Earnings Waterfall
Sonoma Pharmaceuticals Inc

Margins Comparison
Sonoma Pharmaceuticals Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
4.5m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
932.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
271B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
287.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.8B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Sonoma Pharmaceuticals Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
4.5m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
932.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
271B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
236.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
224.8B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
287.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
153.8B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
121B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Sonoma Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett